Drug development costs: Is $2.6B correct? Big pharma may profit from inflated estimates.
Drug costs are astronomical – this we know. But we don’t have a transparent, informed way of calculating – or understanding – the true costs of drug development, argued Dr. Jerry Avorn, a professor of pharmacoeconomics at Harvard University, in this week’s New England Journal of Medicine. And this ignorance may be helping big pharma inflate the price of drugs. He […]